BTIG Research Downgraded Medtronic PLC (MDT)

Medtronic PLC (NYSE:MDT) was downgraded by equities research analysts at BTIG Research from a “buy” rating to a “neutral” rating in a research note issued on Wednesday, The Fly reports.

Shares of Medtronic PLC (NYSE:MDT) opened at 80.48 on Wednesday. The stock has a market capitalization of $112.76 billion and a price-to-earnings ratio of 47.51. The firm’s 50-day moving average is $79.65 and its 200-day moving average is $76.88. Medtronic PLC has a 52 week low of $55.54 and a 52 week high of $82.00.

Medtronic PLC (NYSE:MDT) last announced its quarterly earnings data on Tuesday, May 31st. The medical technology company reported $1.27 EPS for the quarter, beating the Zacks’ consensus estimate of $1.26 by $0.01. During the same quarter in the previous year, the business posted $1.16 earnings per share. The firm earned $7.57 billion during the quarter, compared to the consensus estimate of $7.49 billion. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. On average, equities research analysts anticipate that Medtronic PLC will post $4.37 EPS for the current fiscal year.

8 Dividend Aristocrats That Also Offer Stock Price Growth

These stocks offer more benefits than just a consistently growing dividend Many investors are drawn to the consistency of dividen...